- Processing Solutions
- Agitators
- Asset Management
- Automation
- Blowers & Fans
- Centrifuges
- Chillers
- Compressors
- Conveyors
- Dryers & Evaporators
- Feeders
- Filtration & Separation
- Flowmeters
- Fluid Flow
- Heat Exchangers
- Instrumentation
- Level Measurement
- Maintenance & Safety
- Mixing & Blending
- Motors & Drives
- Oil Skimmers
- Piping & Tubing
- Packaging Equipment
- Powder & Bulk Solids
- Process Control
- Pumps & Seals
- Size Reduction
- Tanks & Vessels
- Valves & Actuators
- Weighing
- More
- Newsletters
- White Papers
- Buyer's Guide
- Videos
- Events
- Advertise
View Cart (0 items)
Pharmaceutical
Subscribe
Pfizer elects Ian Read as chairman of the board
December 13, 2011
No Comments
NEW YORK — Pfizer Inc. announced Monday that its Board of Directors has elected current President and CEO Ian Read as chairman of the board, according to a press
Read More
Merck to establish R&D headquarters in Beijing
December 6, 2011
BEIJING — Pharmaceutical company Merck & Co. announced plans to establish an Asian R&D headquarters in Beijing and commit $1.5 billion to research and development in China over the
Read More
Parents claim Zoloft caused birth defects
December 1, 2011
ST. CLAIR COUNTY, Ill. — A recently filed lawsuit against Pfizer claims the ingestion of Zoloft during pregnancy led eight different couples to parent children with various birth defects,
Read More
Onyx Pharmaceuticals considers sale
November 29, 2011
SAN FRANCISCO — Onyx Pharmaceuticals Inc., known for its kidney-cancer treatment Nexavar, is exploring options, including a possible sale, according to Bloomberg. Potential buyers are studying Onyx''s business and
Read More
Pfizer to acquire Excaliard Pharmaceuticals
November 22, 2011
NEW YORK and SAN DIEGO — Pfizer Inc. and Excaliard Pharmaceuticals, Inc. announced today that they have entered into a definitive agreement under which Pfizer will acquire Excaliard, a
Read More
Bayer sells Mishawaka, Ind., manufacturing site to Siemens
November 17, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More
Bayer aims to increase sales in Asia by 60 percent
November 16, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More
Merck settles Vioxx lawsuits
November 15, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More
Bristol-Myers, Lilly receive FDA approval to market cancer drug for wider use
November 8, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More
ASLAN Pharmaceuticals, Bristol-Myers Squibb partner to develop cancer treatment
November 3, 2011
Normal0falsefalsefalseEN-USX-NONEX-NONEMicrosoftInternetExplorer4 /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-priority:99; mso-style-qformat:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin-top:0in; mso-para-margin-right:0in; mso-para-margin-bottom:10.0pt; mso-para-margin-left:0in; line-height:115%; mso-pagination:widow-orphan; font-size:11.0pt; font-family:"Calibri","sans-serif"; mso-ascii-font-family:Calibri; mso-ascii-theme-font:minor-latin; mso-fareast-font-family:"Times New
Read More
